Perrigo (PRGO) Retained Earnings (2013 - 2026)
Perrigo (PRGO) posted quarterly Retained Earnings of -$3.0 million for Q1 2026, up 99.87% year-over-year from -$1.5 million in Q1 2025, and up 99.92% quarter-over-quarter from -$3.7 billion in Q4 2025.
Perrigo (PRGO) Retained Earnings (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Retained Earnings for 14 consecutive years, with -$3.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings rose 99.87% year-over-year to -$3.0 million; the TTM figure through Mar 2026 stood at -$3.0 million (up 99.87% YoY), while the FY2025 annual figure was -$3.7 billion, down 63.29% from the prior year.
- Retained Earnings climbed to -$3.0 million in Q1 2026 per PRGO's latest filing, from -$3.7 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $75.0 million in Q2 2025 and bottomed at -$3.7 billion in Q4 2025.
- Historically, Retained Earnings has averaged -$1.5 billion across 5 years, with a median of -$2.1 billion in 2022.
- Annual changes were most pronounced in 2023 — Retained Earnings sank 13904.0% — and 2025, when it surged 238.38%.
- Perrigo's Retained Earnings stood at -$2.1 billion in 2022, then slipped by 0.61% to -$2.1 billion in 2023, then slipped by 8.26% to -$2.3 billion in 2024, then plunged by 63.29% to -$3.7 billion in 2025, then jumped by 99.92% to -$3.0 million in 2026.
- Business Quant data shows PRGO's Retained Earnings at -$3.0 million in Q1 2026, -$3.7 billion in Q4 2025, and -$2.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn | -4.00 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | -4.00 Bn |
| Mar 28, 2026 | -3.00 Mn |
| Dec 31, 2025 | -3.68 Bn |
| Sep 27, 2025 | -2.26 Bn |
| Jun 28, 2025 | 75.00 Mn |
| Mar 29, 2025 | -2.26 Bn |
| Dec 31, 2024 | -2.25 Bn |
| Sep 28, 2024 | -2.21 Bn |
| Jun 29, 2024 | -54.20 Mn |
| Mar 30, 2024 | -2.08 Bn |
| Dec 31, 2023 | -2.08 Bn |
| Sep 30, 2023 | -2.05 Bn |
| Jul 1, 2023 | 19.90 Mn |
| Apr 1, 2023 | -2.07 Bn |
| Dec 31, 2022 | -2.07 Bn |
| Oct 1, 2022 | -2.04 Bn |
| Jul 2, 2022 | -146.80 Mn |
| Apr 2, 2022 | 15.00 Mn |
| Dec 31, 2021 | 35.50 Mn |
| Oct 2, 2021 | 54.20 Mn |